S0910 Epratuzumab, Cytarabine, and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
81 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- Usc/norris Comprehensive Cancer Center and Hospital
Los Angeles, California, United States
- University of California Davis Cancer Center
Sacramento, California, United States
- Stanford Cancer Center
Stanford, California, United States
- University of Colorado Cancer Center at Uc Health Sciences Center
Aurora, Colorado, United States
- St. Mary'S Regional Cancer Center at St. Mary'S Hospital and Medical Center
Grand Junction, Colorado, United States
- H. Lee Moffitt Cancer Center and Research Institute at University of South Florida
Tampa, Florida, United States
- Cardinal Bernardin Cancer Center at Loyola University Medical Center
Maywood, Illinois, United States
- St. Francis Hospital and Health Centers - Beech Grove Campus
Beech Grove, Indiana, United States
- Reid Hospital & Health Care Services
Richmond, Indiana, United States
- Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana, United States
- Hematology-Oncology Clinic
Baton Rouge, Louisiana, United States
- University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, United States
- University of Mississippi Cancer Clinic
Jackson, Mississippi, United States
- Saint Louis University Cancer Center
St Louis, Missouri, United States
- Billings Clinic - Downtown
Billings, Montana, United States
- Ccop - Montana Cancer Consortium
Billings, Montana, United States
- Hematology-Oncology Centers of the Northern Rockies - Billings
Billings, Montana, United States
- St. Vincent Healthcare Cancer Care Services
Billings, Montana, United States
- Bozeman Deaconess Cancer Center
Bozeman, Montana, United States
- Great Falls Clinic - Main Facility
Great Falls, Montana, United States
- Sletten Cancer Institute at Benefis Healthcare
Great Falls, Montana, United States
- St. Peter'S Hospital
Helena, Montana, United States
- Glacier Oncology, Pllc
Kalispell, Montana, United States
- Kalispell Regional Medical Center
Kalispell, Montana, United States
- Montana Cancer Center at St. Patrick Hospital and Health Sciences Center
Missoula, Montana, United States
- Montana Cancer Specialists at Montana Cancer Center
Missoula, Montana, United States
- James P. Wilmot Cancer Center at University of Rochester Medical Center
Rochester, New York, United States
- Presbyterian Cancer Center at Presbyterian Hospital
Charlotte, North Carolina, United States
- Charles M. Barrett Cancer Center at University Hospital
Cincinnati, Ohio, United States
- Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio, United States
- Ccop - Dayton
Dayton, Ohio, United States
- David L. Rike Cancer Center at Miami Valley Hospital
Dayton, Ohio, United States
- Good Samaritan Hospital
Dayton, Ohio, United States
- Grandview Hospital
Dayton, Ohio, United States
- Samaritan North Cancer Care Center
Dayton, Ohio, United States
- Blanchard Valley Medical Associates
Findlay, Ohio, United States
- Middletown Regional Hospital
Franklin, Ohio, United States
- Wayne Hospital
Greenville, Ohio, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2010
- Primary completion
- 31 Mar 2013
- Completion
- 31 Aug 2017
- Last update posted
- 6 Nov 2017
- Registered enrollment
- 35
- Registry id
- NCT00945815
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.